Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aclaris Therapeutics (ACRS) Short term Debt (2017)

Historic Short term Debt for Aclaris Therapeutics (ACRS) over the last 1 years, with Q4 2017 value amounting to $590000.0.

  • Aclaris Therapeutics' Short term Debt changed N/A to $590000.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $590000.0, marking a year-over-year change of. This contributed to the annual value of $590000.0 for FY2017, which is N/A changed from last year.
  • According to the latest figures from Q4 2017, Aclaris Therapeutics' Short term Debt is $590000.0.
  • Aclaris Therapeutics' Short term Debt's 5-year high stood at $590000.0 during Q4 2017, with a 5-year trough of $590000.0 in Q4 2017.